Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus
Eric A. Schwartz, Juraj Koska, Michael P. Mullin, Iyad Syoufi, Dawn C. Schwenke, Peter D. Reaven
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus'. Together they form a unique fingerprint.